A G Ziegler

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 310 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.

Ezio Bonifacio, Vito Lampasona, Luca Bernasconi et al. · Diabetes · 2000 · 100 citations · Full text

Middle Gad65 Epitopes, Autoimmune Disease, Allergy +14

Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay

Heike E. Naserke, Nicoletta Dozio, A G Ziegler et al. · Diabetologia · 1998 · 74 citations · Full text

Insulin Autoantibodies, Autoimmune Disease, Allergy +10

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.

J. Dittler, D. Seidel, M Schenker et al. · Diabetes · 1998 · 63 citations

Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

H. U. Janka, A G Ziegler, Eberhard Standl et al. · PubMed · 1987 · 59 citations

Hypertension, Non-insulin-dependent Diabetics, Daily Insulin Dose +16